• Apr 14, 2020 | Webinar

    ASBMR Webinar Panel on Treating Patients with Osteoporosis During the COVID-19 Pandemic

    Matthew Drake, M.D., Ph.D., Mayo Clinic, Rochester, Minnesota, USA, Doug Bauer, M.D., University of California, San Francisco, California, USA, Bart Clarke, M.D., Mayo Clinic, Rochester, Minnesota, USA, Elena Tsourdi, M.D., Technische Universität Dresden, Germany, Elaine Yu, M.D., MMSc, Massachusetts General Hospital, Harvard Medical School, Boston, USA

    Click here to listen to the ASBMR Webinar Panel: Treating Patients with Osteoporosis During the COVID-19 Pandemic that took place on Tuesday, April 14, 2020. The webinar featured a panel of clinical experts in bone discussing timely topics related to osteoporosis treatment and the COVID-19 pandemic, including:

    • Prolia® (denosumab) and the immune system
    • Approaches to transitioning patients from Prolia® (denosumab)
    • Timing of Evenity® (romosozumab) and possible transition to other treatments
    • Transition from skeletal anabolics to antiresorptives

    Amgen recommends the use of its products only in accordance with the Food and Drug Administration (FDA)-approved prescribing information. Please refer to the full prescribing information for approved product labeling and important safety information - https://www.amgenmedinfo.com/Home

    Access to this recording is free. To access the recording, create an account on www.asbmr.org, if you do not already have one, and login to listen.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details